News

How CD57 Markers Can Help Lyme Disease Treatment

Lyme disease affects thousands of Americans. Each year, roughly 20,000 to 30,000 new cases are confirmed nationwide. When a person develops Lyme disease, they may experience mild illness that can be treated effectively using antibiotics. However, that isn’t always the case. Some people who contract the bacteria that causes Lyme disease end up developing long-term complications and issues that impact the health of their entire body. The bacteria that causes the disease, borrelia, can evade detection, even when someone takes medication to get rid of it. Because of this, it can hide in plain sight, causing damage to organs, tissues, and healthy cells.

In the past, it wasn’t always easy to diagnose Lyme disease, especially cases that went unnoticed until months after a person contracted it. However, new diagnostic tools have emerged, helping medical providers diagnose and treat Lyme disease more effectively. One such type of diagnostic investigation is checking a person’s CD57 markers. Read on to learn more about CD57 markers and how CD57 markers can help Lyme disease treatment.

Continue reading “How CD57 Markers Can Help Lyme Disease Treatment”
tick on flower
News

How Borrelia’s Unusual Peptidoglycan Could Alter How We Treat & Target Lyme Disease

Lyme disease is a bacterial infection caused by the borrelia burgdorferi bacteria. The infection is notoriously difficult to treat. The only option is currently antibiotics, and in roughly 20% of cases, people who have gone through treatment still go on to develop chronic Lyme – a persistent form of the disease that can continue to wreak havoc on the body long after the initial infection has subsided.

Scientific researchers have spent years studying the structure, function, and illness caused by Lyme bacteria in an effort to develop a better way to rid a person of the infection. While a lot of that research has been helpful, we haven’t yet devised a new treatment or cure for Lyme. However, new research surrounding borrelia’s unusual peptidoglycan may change everything in regard to Lyme disease and how it’s treated.

Continue reading “How Borrelia’s Unusual Peptidoglycan Could Alter How We Treat & Target Lyme Disease”
dna chain
News

The Future Of Genome Editing & Lyme Disease

When thinking about insects and disease, many people may not initially consider ticks. However, ticks can spread Lyme disease and other tick-borne disease such as Rocky Mountain Spotted Fever and anaplasmosis. These conditions can be difficult to diagnose, treat, and manage, especially Lyme disease.

Research is constantly bringing to light new information about the biology of ticks and how they spread disease, and this insight can be used to further aid in the prevention of tick-borne disease cases across the globe. One particular group of researchers have sought to understand the tick further through genome editing. So what’s in store for the future of genome editing and Lyme disease? Read on to learn more.

Continue reading “The Future Of Genome Editing & Lyme Disease”
close up picture of tick
News

The Role of NapA Protein On Inflammation In Lyme Patients

Lyme disease occurs when the borrelia bacteria is transmitted from an infected tick. The first signs of infection are similar to that of a flu, and people are often unaware that they have Lyme disease at all. When they do get treated with antibiotics, it has long been thought that the Lyme-causing bacteria could evade detection and continue to cause health problems because of its ability to hide out in tissues. Researchers believe that when this happens, it leads to the host of symptoms and a condition known as post-Lyme disease syndrome.

Post-Lyme disease syndrome can lead to various health effects such as fatigue, restless sleep, aching joints or muscles, cognitive issues (such as speech problems or decreased short-term memory), and swelling in the knees, shoulders, and other large joints. When the borrelia bacteria stays in the body long enough to cause post-Lyme disease syndrome, it can also lead to inflammation that can cause permanent damage if it is left untreated.

Lyme disease has puzzled researchers for years, but new findings may have uncovered a link between a specific protein known as the NapA protein and its role in Lyme-induced inflammation and arthritis. Read on to learn all you need to know about this connection.

Continue reading “The Role of NapA Protein On Inflammation In Lyme Patients”
Infectolab - supplements
News

Which Nutritional Supplements Best Support Lyme Treatment And Why?

Lyme disease can be debilitating, especially if it is not treated quickly following initial transmission. When the bacteria that causes Lyme disease is left to its own devices, it can cause a myriad of health issues. Some symptoms of chronic Lyme disease, such as Lyme arthritis, cognitive dysfunction, and cardiovascular issues, can all linger long after antibiotic treatment.

When post-Lyme disease syndrome does occur, coping with the symptoms can be difficult. But certain supplementation can help a person with chronic Lyme disease symptoms manage their ailments better. Even though the following supplements for Lyme disease will not cure the bacterial infection, they can be helpful in the treatment and recovery process.

Continue reading “Which Nutritional Supplements Best Support Lyme Treatment And Why?”